Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

EPIGENSISPHARMACEUTICALS

EPIGENSIS
PHARMACEUTICALSDevelop inhaled respiratory medicines that are safe, effective and improve the health and quality of life in patients with asthma, obstructive pulmonary disease (COPD), and other respiratory diseases.
Develop inhaled respiratory medicines with commercially attractive target product profiles that address the unmet medical needs of patients with asthma and COPD, two of the largest growth markets in the foreseeable future.
Create shareholder value through timely execution of our development plans and effectively managing our financial and human resources.


Contact Details:
2009 Eastpark Boulevard
Cranbury
New Jersey
08512
United States of America
Tel:609-409-6080
Fax:609-409-6126
Email:info@epigene.com
WWW:

www.epigene.com/




Loading...

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 198 times since April 2007, the link to the organisation's website has been followed 43 times

Search for more companies in Cranbury

Search for more companies in New Jersey



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for EPIGENSISPHARMACEUTICALS

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.